Global

Researchers using genetics, data science to study why COVID-19 is more severe in some people

Thu, 2023-10-26 10:24 — mike kraft

Why is COVID-19 more severe in some people? Researchers use genetics, data science to find out Why do some people have a more severe course of COVID-19 disease than others? A genome sequence database created by an international collaboration of researchers, including many from the University of ... Tyler Irving Medical Xpress

Why do some people have a more severe course of COVID-19 disease than others? A genome sequence database created by an international collaboration of researchers, including many from the University of Toronto and partner hospitals, may hold the answers to this question—and many more.

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about Researchers using genetics, data science to study why COVID-19 is more severe in some people
Log in or register to post comments

Severe mental illness linked to 50% increase in COVID-related death--British study

Thu, 2023-10-26 10:15 — mike kraft

Severe mental illness linked to 50% increase in COVID-related death The study was based on outcomes seen among 660,000 UK patients from February 2020 to April 2021. CIDRAP

People with severe mental illness (SMI) are at a 50% increased risk of death from all causes following COVID-19 infections, according to a study yesterday in The British Journal of Psychiatry.

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about Severe mental illness linked to 50% increase in COVID-related death--British study
Log in or register to post comments

Pfizer’s says its combination Covid, flu vaccine will move to final-stage trial after positive data

Thu, 2023-10-26 10:07 — mike kraft

Pfizer combination Covid, flu vaccine shows positive trial data (cnbc.com)

Pfizer said its combination vaccine candidates targeting Covid and the flu will move to a final-stage trial in the coming months after showing positive initial results. ..
Pfizer and other vaccine makers like Moderna and Novavax believe combination shots will simplify the process for people to protect themselves against respiratory viruses that typically surge around the same time of the year.
...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Getting flu and COVID shot together still reasonable amid safety review of potential stroke risk: Experts

Thu, 2023-10-26 09:31 — mike kraft

COVID shot together still reasonable amid safety review of potential stroke risk: Experts Older adults who received last year’s COVID booster and a high-dose version of the flu vaccine in the same visit may have a potential increased risk of stroke, according to a new FDA-funded study. Experts urged that the results were preliminary and may be explained by other factors such as the fact that older adults are already at a higher risk for stroke due to their age. "There is no need for panic, and emphatically no need to stop giving COVID and flu shots at the same time to older adults," said Dr. Peter Chin-Hong, an infectious diseases specialist at the University of California, San Francisco, while he reiterated that more research is needed. Yahoo

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Statin linked to improved outcomes in COVID-19 patients, vitamin C shows no benefits--study

Wed, 2023-10-25 18:12 — mike kraft

Statin linked to improved outcomes in COVID-19 patients, vitamin C shows no benefits - UPI.com Clinical trials show vitamin C was not beneficial in critically ill COVID-19 patients, but the statin drug simvastatin had a 96% likelihood of improving outcomes. UPI

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about Statin linked to improved outcomes in COVID-19 patients, vitamin C shows no benefits--study
Log in or register to post comments

GSK says its RSV vaccine shows potential for adults in their 50's

Wed, 2023-10-25 09:57 — mike kraft

GSK's common respiratory virus vaccine shows potential in adults aged 50-59 GSK said its vaccine for respiratory syncytial virus (RSV) showed positive preliminary results in a late-stage trial to protect adults aged 50 to 59 from the disease that causes thousands of hospitalisations and deaths annually. Reuters Reuters

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about GSK says its RSV vaccine shows potential for adults in their 50's
Log in or register to post comments

Moderna begins phase 3 clinical trial of combo flu, COVID vaccine

Wed, 2023-10-25 09:49 — mike kraft

Moderna doses 1st participant in phase 3 clinical trial of combo flu, COVID vaccine Moderna announced the first participant has been dosed in the company's phase 3 clinical trial of its combination flu and COVID vaccine. ABC News ABC News

...

In a press release, the biopharmaceutical company said the combination vaccine has "the potential to efficiently reduce the overall burden of acute viral respiratory disease" by giving simultaneous protection against flu and COVID in a single dose.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Moderna begins phase 3 clinical trial of combo flu, COVID vaccine
Log in or register to post comments

People with HIV at higher risk of COVID reinfection -- CDC study

Tue, 2023-10-24 11:12 — mike kraft

People with HIV at higher risk of COVID reinfection: CDC A new CDC study found people with HIV were more likely to be reinfected with COVID than those without HIV. ABC News ABC News

...

Rates of reinfection were higher among people with HIV (6.7%) than among people without HIV (5.2%).

People with HIV are more likely to have completed a primary COVID vaccine series plus a booster before their reinfection -- 31.8% versus 27% for those without HIV.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about People with HIV at higher risk of COVID reinfection -- CDC study
Log in or register to post comments

Children with COVID continued to shed virus for median of 3 days, supporting school-isolation policies --study

Tue, 2023-10-24 10:56 — mike kraft

Study: Kids with COVID shed virus for median of 3 days, supporting school-isolation policies iStock CIDRAP

Children who tested positive for COVID-19 in 2022 were contagious for a median of 3 days, regardless of vaccination status, suggesting that 5-day school isolation policies are sufficient amid Omicron variant predominance, University of Southern California (USC) and Stanford University researchers report today in JAMA Pediatrics.

...

Country / Region Tags:

General Topic Tags: